HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
POMC
proopiomelanocortin
Chromosome 2 Β· 2p23.3
NCBI Gene: 5443Ensembl: ENSG00000115138.12HGNC: HGNC:9201UniProt: P01189
339PubMed Papers
22Diseases
0Drugs
20Pathogenic Variants
FUNCTIONAL ROLE
Hub Gene
RESEARCH IMPACT
Highly Studied
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
positive regulation of transcription by RNA polymerase IIsignaling receptor bindingGO:0005615hormone activityobesity due to pro-opiomelanocortin deficiencyobesityinherited obesitygenetic disorder
✦AI Summary

POMC (proopiomelanocortin) is a precursor polypeptide that serves as the source of multiple bioactive peptides critical for energy homeostasis and stress response 1. The primary function of POMC involves its tissue-specific processing by prohormone convertases PC1 and PC2 into various peptide products including ACTH, Ξ²-lipotropin, Ξ±-MSH, Ξ²-endorphin, and other melanocortin and opioid peptides 1. In the hypothalamus, POMC neurons function as key appetite-suppressing components of the melanocortin system, responding to leptin and other metabolic signals to regulate food intake and energy expenditure through Ξ±-MSH activation of MC4 receptors 23. POMC transcription is tightly regulated through multiple pathways including glucocorticoid feedback, CRH signaling, and developmental transcription factors like Tpit 45. Disease relevance is significant, as POMC mutations cause severe early-onset obesity with adrenal insufficiency and red hair due to disrupted melanocortin signaling 36. Additionally, ectopic POMC expression in tumors can cause Cushing's syndrome through aberrant ACTH production 7. The gene's complex evolutionary history reflects its dual role in both opioid and melanocortin signaling systems 8.

Sources cited
1
POMC is a precursor polypeptide processed by PC1 and PC2 convertases into multiple bioactive peptides including ACTH, Ξ²-lipotropin, and Ξ²-endorphin
PMID: 7805649
2
POMC neurons function as appetite-suppressing components that respond to metabolic signals to regulate food intake and energy expenditure
PMID: 33633406
3
POMC mutations cause severe early-onset obesity and POMC-derived Ξ±-MSH activates MC4 receptors to reduce food intake
PMID: 34238466
4
POMC transcription is regulated by multiple pathways including glucocorticoid feedback and developmental transcription factors
PMID: 26792828
5
POMC promoter regulation involves glucocorticoid response elements and transcription factor cooperation
PMID: 21464606
6
POMC deletion studies revealed its substantial role in body weight regulation and adrenal function
PMID: 26643913
7
Ectopic POMC expression in tumors can cause Cushing's syndrome through aberrant ACTH production
PMID: 12055989
8
POMC has a complex evolutionary history involving both opioid and melanocortin receptor systems
PMID: 31421696
Disease Associationsβ“˜22
obesity due to pro-opiomelanocortin deficiencyOpen Targets
0.70Moderate
obesityOpen Targets
0.60Moderate
inherited obesityOpen Targets
0.42Moderate
genetic disorderOpen Targets
0.41Moderate
autoimmune diseaseOpen Targets
0.40Weak
adrenal gland diseaseOpen Targets
0.37Weak
uterine fibroidOpen Targets
0.36Weak
Abnormality of skin pigmentationOpen Targets
0.35Weak
cardiovascular diseaseOpen Targets
0.32Weak
hypertensionOpen Targets
0.32Weak
inflammatory spondylopathyOpen Targets
0.30Weak
Crohn's diseaseOpen Targets
0.30Weak
ulcerative colitisOpen Targets
0.29Weak
atrial fibrillationOpen Targets
0.28Weak
mental or behavioural disorderOpen Targets
0.27Weak
substance-related disorderOpen Targets
0.27Weak
inflammatory bowel diseaseOpen Targets
0.25Weak
hair colorOpen Targets
0.13Weak
Abnormality of the skeletal systemOpen Targets
0.13Weak
Pituitary Gland AdenomaOpen Targets
0.13Weak
ObesityUniProt
Obesity, early-onset, with adrenal insufficiency and red hairUniProt
Pathogenic Variants20
NM_000939.4(POMC):c.-11C>APathogenic
Obesity due to pro-opiomelanocortin deficiency|not provided|Obesity due to pro-opiomelanocortin deficiency;Obesity|Early onset severe obesity
β˜…β˜…β˜†β˜†2024
NM_000939.4(POMC):c.132+1G>APathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜…β˜†β˜†β˜†2025
NM_000939.4(POMC):c.214G>T (p.Glu72Ter)Likely pathogenic
Early onset severe obesity
β˜…β˜†β˜†β˜†2024β†’ Residue 72
NM_000939.4(POMC):c.434G>T (p.Arg145Leu)Likely pathogenic
POMC-related disorder|Early onset severe obesity
β˜…β˜†β˜†β˜†2023β†’ Residue 145
NM_000939.4(POMC):c.48del (p.Leu16fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2023β†’ Residue 16
NM_000939.4(POMC):c.34del (p.Leu12fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2019β†’ Residue 12
NM_000939.4(POMC):c.84C>A (p.Cys28Ter)Pathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜…β˜†β˜†β˜†2018β†’ Residue 28
NM_000939.4(POMC):c.416dup (p.Tyr139Ter)Pathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜…β˜†β˜†β˜†2018β†’ Residue 139
NM_000939.4(POMC):c.55C>T (p.Gln19Ter)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 19
NM_000939.4(POMC):c.251G>A (p.Trp84Ter)Pathogenic
not provided|POMC-related disorder
β˜…β˜†β˜†β˜†2018β†’ Residue 84
NM_000939.4(POMC):c.225del (p.Lys76fs)Pathogenic
not provided
β˜…β˜†β˜†β˜†2018β†’ Residue 76
NM_000939.4(POMC):c.133-2A>CPathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜…β˜†β˜†β˜†2016
NM_000939.4(POMC):c.20_21insGGGCCCTCGGGGGCCCCTCGGGTGG (p.Ser7fs)Pathogenic
Inborn genetic diseases|POMC-related disorder
β˜…β˜†β˜†β˜†2014β†’ Residue 7
NM_001035256.2(POMC):c.20_21ins25Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†
NM_000939.4(POMC):c.180del (p.Met60fs)Likely pathogenic
Obesity
β˜…β˜†β˜†β˜†β†’ Residue 60
NM_000939.4(POMC):c.151A>T (p.Lys51Ter)Pathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜†β˜†β˜†β˜†2003β†’ Residue 51
NM_000939.4(POMC):c.403_404dup (p.Lys136fs)Pathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜†β˜†β˜†β˜†2003β†’ Residue 136
NM_000939.4(POMC):c.433del (p.Arg145fs)Pathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜†β˜†β˜†β˜†1998β†’ Residue 145
NM_000939.4(POMC):c.313G>T (p.Glu105Ter)Pathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜†β˜†β˜†β˜†1998β†’ Residue 105
NM_000939.4(POMC):c.-21+1G>APathogenic
Obesity due to pro-opiomelanocortin deficiency
β˜†β˜†β˜†β˜†
View on ClinVar β†—
Related Genes
ATP7AProtein interaction100%MC1RProtein interaction100%MC5RProtein interaction100%NUCB2Protein interaction99%TBX19Protein interaction99%UCP2Protein interaction98%
Tissue Expression6 tissues
Ovary
100%
Liver
84%
Lung
57%
Heart
31%
Bone Marrow
30%
Brain
30%
Gene Interaction Network
Click a node to explore
POMCATP7AMC1RMC5RNUCB2TBX19UCP2
PROTEIN STRUCTURE
Preparing viewer…
PDB4XNH Β· 2.10 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.80LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.30 [0.94–1.80]
RankingsWhere POMC stands among ~20K protein-coding genes
  • #951of 20,598
    Most Researched339 Β· top 5%
  • #2,176of 5,498
    Most Pathogenic Variants20
  • #16,544of 17,882
    Most Constrained (LOEUF)1.80
Genes detectedPOMC
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
Proopiomelanocortin-derived peptides.
PMID: 7805649
Endocrinol Metab Clin North Am Β· 1994
1.00
2
POMC neuronal heterogeneity in energy balance and beyond: an integrated view.
PMID: 33633406
Nat Metab Β· 2021
0.90
3
Ectopic pro-opiomelanocortin syndrome.
PMID: 12055989
Endocrinol Metab Clin North Am Β· 2002
0.80
4
Evolution of proopiomelanocortin.
PMID: 31421696
Vitam Horm Β· 2019
0.70
5
Developmental programming of hypothalamic melanocortin circuits.
PMID: 35474338
Exp Mol Med Β· 2022
0.68